Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Xianming, Chu"'
Autor:
Daisong Li, Yanyan Yang, Shizhong Wang, Xiangqin He, Meixin Liu, Baochen Bai, Chao Tian, Ruicong Sun, Tao Yu, Xianming Chu
Publikováno v:
Redox Biology, Vol 46, Iss , Pp 102089- (2021)
As a potent chemotherapeutic agent, doxorubicin (DOX) is widely used for the treatment of a variety of cancers However, its clinical utility is limited by dose-dependent cardiotoxicity, and pathogenesis has traditionally been attributed to the format
Externí odkaz:
https://doaj.org/article/0c46f8765c0f4c528a88755b530ff2df
Autor:
Tao Xu, Wei Ding, Xiang Ao, Xianming Chu, Qinggong Wan, Yu Wang, Dandan Xiao, Wanpeng Yu, Mengyang Li, Fei Yu, Jianxun Wang
Publikováno v:
Redox Biology, Vol 20, Iss , Pp 414-426 (2019)
Necrosis is a key factor in myocardial injury during cardiac pathological processes, such as myocardial infarction (MI), ischemia/reperfusion (I/R) injury and heart failure. Increasing evidence suggests that several aspects of necrosis are programmed
Externí odkaz:
https://doaj.org/article/c7841e8e90794cde8d010b9a71c37713
Publikováno v:
International Immunopharmacology. 116:109770
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4139d388f1c39cdc457723c8e544d2f4
https://doi.org/10.1016/j.intimp.2023.109770
https://doi.org/10.1016/j.intimp.2023.109770
Autor:
Qinchao, Wu, Daisong, Li, Chao, Huang, Guoliang, Zhang, Zheng, Wang, Jiane, Liu, Haichu, Yu, Bingxue, Song, Ning, Zhang, Bing, Li, Xianming, Chu
Publikováno v:
Biomedicine & Pharmacotherapy. 153:113517
Patients with type 2 diabetes mellitus (T2DM) face a high risk of developing cardiovascular diseases. However, traditional hypoglycemic drugs have limited effects on macrovascular complications of the disease. Clinical trials have confirmed that gluc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109defabac7edb95208526f49f322dbb
https://doi.org/10.1016/j.biopha.2022.113517
https://doi.org/10.1016/j.biopha.2022.113517
Autor:
Xilong Tang, Tingru Sun, Xi Yang, Haichu Yu, Xianming Chu, Yonghong Li, Xin Liu, Jingwei Zhou, Qingke Xu, Liang Peng, Junjie Guo
Publikováno v:
Physiol Res
Valsartan has the potential to attenuate neointimal hyperplasia and to suppress the inflammatory response. This study aimed to evaluate the role of valsartan in neointimal hyperplasia and the toll-like receptor 4 (TLR4)-nitric oxide synthase (NOS) pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02c45ea542fc0e1e07983469344964fb
https://europepmc.org/articles/PMC8820538/
https://europepmc.org/articles/PMC8820538/
Autor:
Xianming Chu, Haichu Yu, Chao Tian, Bing Li, Bingxue Song, Daisong Li, Qinchao Wu, Baochen Bai
Publikováno v:
Cardiovascular drugs and therapy. 36(3)
In recent decades, there has been a revolutionary decrease in cancer-related mortality and an increase in survival due to the introduction of novel targeted drugs. Nevertheless, drugs targeting human epidermal growth factor receptor 2 (HER-2), angiog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57820ead28fdebba2b25b8bbe078c84b
https://pubmed.ncbi.nlm.nih.gov/33847848
https://pubmed.ncbi.nlm.nih.gov/33847848
Autor:
Rui-Cong Sun, Xianming Chu, Tao Yu, Chao Tian, Baochen Bai, Xiangqin He, Daisong Li, Yanyan Yang, Shizhong Wang, Meixin Liu
Publikováno v:
Redox Biology
Redox Biology, Vol 46, Iss, Pp 102089-(2021)
Redox Biology, Vol 46, Iss, Pp 102089-(2021)
As a potent chemotherapeutic agent, doxorubicin (DOX) is widely used for the treatment of a variety of cancers However, its clinical utility is limited by dose-dependent cardiotoxicity, and pathogenesis has traditionally been attributed to the format
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ac299f4f4af9708dca9b95ca598d28a
https://doi.org/10.1016/j.redox.2021.102089
https://doi.org/10.1016/j.redox.2021.102089
Autor:
Chunming Dong, Qi Ma, Shoukang Zhu, Derek M. Dykxhoorn, Chunling Jia, Wei Zhu, Huilan Wang, Shanming Deng, Emily Chen, Conrad Macon, Xianming Chu, Dushyantha Jayaweera, Jianqin Wei
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 37:280-290
Objective— Lineage-negative bone marrow cells (lin− BMCs) are enriched in endothelial progenitor cells and mediate vascular repair. Aging-associated senescence and apoptosis result in reduced number and functionality of lin− BMCs, impairing the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2e0233094a630527eecc2e041d4a5b5
https://doi.org/10.1161/atvbaha.116.308378
https://doi.org/10.1161/atvbaha.116.308378
Autor:
Xi Yang, Xianming Chu, Bo Hou, Junhua Ge, Li Tingting, Shuo Duan, Haichu Yu, Junjie Guo, Yonghong Li, Hui Xu, Jingwei Zhou
Publikováno v:
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology. 49
Purpose Restenosis is the main complication after percutaneous coronary intervention. The proliferation of new intima contributes to the process. In this study, we aimed to explore the effect of olmesartan on intimal thickening after balloon injury a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17e434cd7ba09f530d7fa8e5a1957770
https://pubmed.ncbi.nlm.nih.gov/32585603
https://pubmed.ncbi.nlm.nih.gov/32585603
Autor:
Yonghong LI, Junjie GUO, Haichu YU, Xin LIU, Jingwei ZHOU, Xianming CHU, Qingke XU, Tingru SUN, Liang PENG, Xi YANG, Xilong TANG
Publikováno v:
Physiological Research; Aug2021, Vol. 70 Issue 4, p533-542, 10p